article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). CE Mark follows U.S.

article thumbnail

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

DAIC

They looked at anonymous results for 57,531 adult patients who underwent pulmonary resection—removal of all or part of a lung—between January 2009 and June 2021. occurrence of postoperative PE in patients undergoing a first-time pulmonary resection for lung cancer. occurrence of postoperative VTE and a 1.3%

Cancer 116
article thumbnail

Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing

HCPLive

Sisson discusses the adoption of 2021 ATS / ERS guidelines, as well as the need for complementary testing and imagine to contextualize the full pulmonary patient.

article thumbnail

Forgotten IVC Filters Aren’t SAFE

CardiacWire

IVC filters are used to prevent pulmonary embolism in patients with venous thromboembolism and can’t receive anticoagulation treatment. Encouragingly, the number of annual IVC filter insertions across the study population decreased from 44,680 in 2013 to 19,501 in 2021. years of insertion. However, the U.S. The Takeaway The U.S.

article thumbnail

Abstract 4120743: MEK inhibition for recurring pulmonary valve stenosis in RASopathy patients

Circulation

However, the most recurrent cardiac complication in RASopathies is pulmonary valve stenosis (PVS). Aim:To report compassionate use of MEKi (trametinib) in recurring RASopathy-associated PVS.Method:Retrospective, single-center study at CHU Sainte Justine, Montreal, from 2021 to 2024.Results:After

article thumbnail

The effect of individual exercise rehabilitation program on ischemic burden and cardiac function in patients with ischemic non-obstructive coronary heart disease: a randomized parallel controlled clinical trial

Frontiers in Cardiovascular Medicine

The therapeutic effect, total myocardial ischemic burden (TIB), the effective rate of TIB reduction, pulmonary function indices, cardiac function, and the incidence of adverse events compared between the two groups.ResultsThe intervention group demonstrated a higher effective rate.

article thumbnail

VA-ECOM assisted percutaneous mechanical thrombectomy treatment high-risk pulmonary embolism

Frontiers in Cardiovascular Medicine

BackgroundPercutaneous mechanical thrombectomy (PMT) is increasingly used in the treatment of intermediate and high-risk acute pulmonary embolism (PE), and the treatment of high-risk PE with the aid of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has also been reported. The mortality rate was 27.3% during the 90-day follow-up.